Patrick J. Christmas
CIK: 0001521123
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENXBIO Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Nov 1, 2026RGNX
REGENXBIO Inc.
Award(A)Direct34.7K shares- - Aug 1, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct4.7K shares at avg. $9.69$46K - Feb 1, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct4.7K shares at avg. $11.16$52K - Jan 6, 2026RGNX
REGENXBIO Inc.
Award(A)Direct73.7K shares- - Jan 2, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct9.8K shares at avg. $14.40$141K - Aug 1, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct4.7K shares at avg. $8.19$38K - Feb 1, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct4.7K shares at avg. $8.07$38K - Jan 2, 2025RGNX
REGENXBIO Inc.
Award(A)DirectStock Options (Right to buy)
223.4K shares- - Jan 2, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct11.4K shares at avg. $7.73$88K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 1, 2026 | RGNX REGENXBIO Inc. | Award(A) | 34,722 | - | $0 | Direct |
| Aug 1, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 4,699 | $9.69 | $45,533 | Direct |
| Feb 1, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 4,700 | $11.16 | $52,452 | Direct |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | Award(A) | 73,749 | - | $0 | Direct |
| Jan 2, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 9,793 | $14.40 | $141,019 | Direct |
| Aug 1, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 4,699 | $8.19 | $38,485 | Direct |
| Feb 1, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 4,700 | $8.07 | $37,929 | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Award(A) Stock Options (Right to buy) | 223,350 | - | - | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 11,395 | $7.73 | $88,083 | Direct |
1-9 of 9 transactions
About Christmas Patrick J.
Christmas Patrick J. (SEC CIK 0001521123) files insider reports with the SEC as Chief Strategy & Legal Officer of REGENXBIO Inc. (RGNX).
Signal8 holds 8 ownership filings by Christmas Patrick J., all Form 4s, filed between Jan 6, 2025 and Nov 3, 2026. Those filings report 9 transactions, from Jan 2, 2025 to Nov 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Christmas Patrick J.'s filings is in ROCKVILLE, MD.
Recent filings by Christmas Patrick J.
- Nov 1, 2026: Grant or award of RGNX shares (Form 4, code A).
- Aug 1, 2026: Tax withholding of RGNX shares (Form 4, code F).
- Feb 1, 2026: Tax withholding of RGNX shares (Form 4, code F).
- Jan 6, 2026: Grant or award of RGNX shares (Form 4, code A).
- Jan 2, 2026: Tax withholding of RGNX shares (Form 4, code F).
Other insiders filing for REGENXBIO Inc. (RGNX)
- Malzahn Craig, Chief Technology Officer
- PAKOLA STEVE, Chief Medical Officer
- Chan Mitchell, Chief Financial Officer
- Ciongoli Gregory Austin, Director
- Simpson Curran, Chief Executive Officer
- Tasse Daniel, Director